| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 49,700 | 44,160 | ||
| General and administrative | 7,318 | 7,566 | ||
| Total operating expenses | 57,018 | 51,726 | ||
| Loss from operations | -57,018 | -51,726 | ||
| Interest and other income, net | 2,096 | 2,570 | ||
| Net loss | -54,922 | -49,156 | ||
| Deemed dividend on modification of common stock warrants | - | 1,857 | ||
| Net loss attributable to common stockholders | -54,922 | -51,013 | ||
| Net loss per share, basic | -0.37 | -0.34 | ||
| Net loss per share, diluted | -0.37 | -0.34 | ||
| Weighted-average shares used in computing net loss per share, basic | 149,123,701 | 148,320,803 | ||
| Weighted-average shares used in computing net loss per share, diluted | 149,123,701 | 148,320,803 | ||
Annexon, Inc. (ANNX)
Annexon, Inc. (ANNX)